Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.91x is 45% above its 5-year average of -3.45x, near the high end of its 5-year range (-128.77x–-0.07x).
34.24% below its 12-month average of -1.42x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -1.09x.
INTEREST COVERAGE RATIO
-1.91x
INTEREST COVERAGE RATIO AVG TTM
-1.42x
INTEREST COVERAGE RATIO AVG 3Y
-2.17x
INTEREST COVERAGE RATIO AVG 5Y
-3.45x
INTEREST COVERAGE RATIO AVG 10Y
-13.62x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-34.24%
CURRENT VS 3Y AVG
+12.14%
CURRENT VS 5Y AVG
+44.63%
CURRENT VS 10Y AVG
+85.98%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 457 covered companies
CURRENT VS SECTOR MEDIAN
+66.13%
vs the sector median at left
Evolus, Inc.
Market Cap
$490.62M
Interest Coverage Ratio
-1.91x
TTM Avg
-1.42x
3Y Avg
-2.17x
5Y Avg
-3.45x
Market Cap
$486.52M
Interest Coverage Ratio
5.63x
TTM Avg
4.06x
3Y Avg
3.16x
5Y Avg
2.54x
Market Cap
$497.40M
Interest Coverage Ratio
-99.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$503.89M
Interest Coverage Ratio
-192.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$474.21M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.82M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.58M
Interest Coverage Ratio
-1.04x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.52M
Interest Coverage Ratio
30.36x
TTM Avg
30.37x
3Y Avg
18.36x
5Y Avg
29.15x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evolus, Inc. (EOLS) | $490.62M | -1.91x | -1.42x | -2.17x | -3.45x |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.52M | 5.63x | 4.06x | 3.16x | 2.54x |
| Oculis Holding AG (OCS)vs › | $497.40M | -99.49x | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $479.39M | N/A | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $503.89M | -192.50x | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $474.21M | N/A | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.82M | N/A | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $472.58M | -1.04x | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $472.52M | 30.36x | 30.37x | 18.36x | 29.15x |
| 908 Devices Inc. (MASS)vs › | $509.64M | N/A | N/A | N/A | N/A |
Interest Coverage
-1.9x
Debt/Equity
N/A
Current Ratio
1.70
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1.09x |
| 2026-03-31 | -1.73x |
| 2025-12-31 | -0.07x |
| 2025-09-30 | -2.81x |
| 2025-06-30 | -1.42x |
| 2025-03-31 | -3.44x |
| 2024-12-31 | -0.51x |
| 2024-09-30 | -3.25x |
| 2024-06-30 | -1.64x |
| 2024-03-31 | -1.90x |
| 2023-12-31 | -2.12x |
| 2023-09-30 | -3.55x |
| 2023-06-30 | -4.75x |
| 2023-03-31 | -4.32x |
| 2022-12-31 | -4.04x |
| 2022-09-30 | -7.64x |
| 2022-06-30 | -10.29x |
| 2022-03-31 | -7.54x |
| 2021-12-31 | -128.77x |
| 2021-09-30 | -61.45x |
| 2021-06-30 | -50.98x |
| 2021-03-31 | 12.44x |
| 2020-12-31 | -38.27x |
| 2020-09-30 | -4.07x |
| 2020-06-30 | -5.48x |
| 2020-03-31 | -11.10x |
| 2019-12-31 | -6.63x |
| 2019-09-30 | -10.24x |
| 2019-06-30 | -14.92x |
| 2019-03-31 | -40.89x |
| 2018-12-31 | -110.69x |
| 2018-09-30 | -35.68x |
| 2018-06-30 | -50.16x |
| 2018-03-31 | -56.50x |
| 2017-09-30 | -1308.00x |
| 2017-06-30 | -2275.00x |
| 2017-03-31 | -3977.00x |
